Skip to main content
Top
Published in: AIDS and Behavior 4/2020

01-04-2020 | Care | Original Paper

Perceptions of Community and Clinic-Based Adherence Clubs for Patients Stable on Antiretroviral Treatment: A Mixed Methods Study

Authors: Mutsa Mudavanhu, Nora S. West, Sheree R. Schwartz, Lillian Mutunga, Valerie Keyser, Jean Bassett, Annelies Van Rie, Colleen F. Hanrahan

Published in: AIDS and Behavior | Issue 4/2020

Login to get access

Abstract

Adherence clubs for patients stable on antiretroviral treatment (ART) offer decongestion of clinics and task-shifting, improved adherence and retention in care. Findings on patient acceptability by club location (in the clinic vs. the community) are limited. This was a mixed-methods study set within a randomized controlled trial of community versus clinic-based adherence clubs for retention in care at Witkoppen Health and Welfare Centre in Johannesburg, South Africa. Participants were surveyed on preferences for adherence club-based care (e.g. location, convenience). We conducted in-depth interviews (IDIs) with 36 participants, and surveyed 568 participants: 49% in community-based clubs and 51% in clinic-based clubs. Participants in both arms favorably rated adherence clubs. Almost all (95%) in clinic-based clubs would recommend them to a friend, while fewer (88% in community-based club participants would do so (p = 0.004). Participants found clubs promoted social support, and were convenient and time-saving, though concerns around stigma and access to other health care were noted within community-based clubs. Adherence clubs are a highly acceptable form of differentiated care for stable ART patients. These data indicate that clinic-based clubs may be preferred above community-based clubs, potentially for reasons of stigma and access to additional health care services.
Appendix
Available only for authorised users
Literature
1.
go back to reference National Department of Health: Republic of South Africa. National Department of Health annual report 2016/2017. National Department of Health: Republic of South Africa; 2017. National Department of Health: Republic of South Africa. National Department of Health annual report 2016/2017. National Department of Health: Republic of South Africa; 2017.
2.
go back to reference World Health Organization. Consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection: recommendations for a public health approach. Geneva: World Health Organization; 2016. World Health Organization. Consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection: recommendations for a public health approach. Geneva: World Health Organization; 2016.
3.
go back to reference National Department of Health: Republic of South Africa. Circular: implementation of the universal test and treat strategy for HIV positive patients and differentiated care for stable patients. National Department of Health: Republic of South Africa; 2016. National Department of Health: Republic of South Africa. Circular: implementation of the universal test and treat strategy for HIV positive patients and differentiated care for stable patients. National Department of Health: Republic of South Africa; 2016.
4.
go back to reference Health Systems Trust. The 90–90–90 Compendium: Volume 2. The clinicians’ guide. Durban: Health Systems Trust; 2017. Health Systems Trust. The 90–90–90 Compendium: Volume 2. The clinicians’ guide. Durban: Health Systems Trust; 2017.
5.
go back to reference Nansseu JR, Bigna JJ. Antiretroviral therapy related adverse effects: can sub-Saharan Africa cope with the new “test and treat” policy of the World Health Organization? Infect Dis Poverty. 2017;6(1):24.CrossRef Nansseu JR, Bigna JJ. Antiretroviral therapy related adverse effects: can sub-Saharan Africa cope with the new “test and treat” policy of the World Health Organization? Infect Dis Poverty. 2017;6(1):24.CrossRef
6.
go back to reference Whiteside A, Cohen J, Strauss M. Reconciling the science and policy divide: the reality of scaling up antiretroviral therapy in South Africa. S Afr J HIV Med. 2015;16(1):355.CrossRef Whiteside A, Cohen J, Strauss M. Reconciling the science and policy divide: the reality of scaling up antiretroviral therapy in South Africa. S Afr J HIV Med. 2015;16(1):355.CrossRef
7.
go back to reference Horter S, Wringe A, Thabede Z, Dlamini V, Kerschberger B, Pasipamire M, et al. “Is it making any difference?” A qualitative study examining the treatment-taking experiences of asymptomatic people living with HIV in the context of Treat-all in Eswatini. J Int AIDS Soc. 2019;22(1):e25220.CrossRef Horter S, Wringe A, Thabede Z, Dlamini V, Kerschberger B, Pasipamire M, et al. “Is it making any difference?” A qualitative study examining the treatment-taking experiences of asymptomatic people living with HIV in the context of Treat-all in Eswatini. J Int AIDS Soc. 2019;22(1):e25220.CrossRef
8.
go back to reference Lumbantoruan C, Kermode M, Giyai A, Ang A, Kelaher M. Understanding women’s uptake and adherence in Option B+ for prevention of mother-to-child HIV transmission in Papua, Indonesia: a qualitative study. PLoS ONE. 2018;13(6):e0198329.CrossRef Lumbantoruan C, Kermode M, Giyai A, Ang A, Kelaher M. Understanding women’s uptake and adherence in Option B+ for prevention of mother-to-child HIV transmission in Papua, Indonesia: a qualitative study. PLoS ONE. 2018;13(6):e0198329.CrossRef
9.
go back to reference Trafford Z, Gomba Y, Colvin CJ, Iyun VO, Phillips TK, Brittain K, et al. Experiences of HIV-positive postpartum women and health workers involved with community-based antiretroviral therapy adherence clubs in Cape Town, South Africa. BMC Public Health. 2018;18(1):935.CrossRef Trafford Z, Gomba Y, Colvin CJ, Iyun VO, Phillips TK, Brittain K, et al. Experiences of HIV-positive postpartum women and health workers involved with community-based antiretroviral therapy adherence clubs in Cape Town, South Africa. BMC Public Health. 2018;18(1):935.CrossRef
10.
go back to reference Zacharius KM, Basinda N, Marwa K, Mtui EH, Kalolo A, Kapesa A. Low adherence to Option B+ antiretroviral therapy among pregnant women and lactating mothers in eastern Tanzania. PLoS ONE. 2019;14(2):e0212587.CrossRef Zacharius KM, Basinda N, Marwa K, Mtui EH, Kalolo A, Kapesa A. Low adherence to Option B+ antiretroviral therapy among pregnant women and lactating mothers in eastern Tanzania. PLoS ONE. 2019;14(2):e0212587.CrossRef
12.
go back to reference National Department of Health: Republic of South Africa. Adherence guidelines for HIV, TB, and NCDs. National Department of Health: Republic of South Africa; 2016. National Department of Health: Republic of South Africa. Adherence guidelines for HIV, TB, and NCDs. National Department of Health: Republic of South Africa; 2016.
13.
go back to reference Luque-Fernandez MA, Van Cutsem G, Goemaere E, Hilderbrand K, Schomaker M, Mantangana N, et al. Effectiveness of patient adherence groups as a model of care for stable patients on antiretroviral therapy in Khayelitsha, Cape Town, South Africa. PLoS ONE. 2013;8(2):e56088.CrossRef Luque-Fernandez MA, Van Cutsem G, Goemaere E, Hilderbrand K, Schomaker M, Mantangana N, et al. Effectiveness of patient adherence groups as a model of care for stable patients on antiretroviral therapy in Khayelitsha, Cape Town, South Africa. PLoS ONE. 2013;8(2):e56088.CrossRef
14.
go back to reference Grimsrud A, Lesosky M, Kalombo C, Bekker LG, Myer L. Implementation and operational research: community-based adherence clubs for the management of stable antiretroviral therapy patients in Cape Town, South Africa: a cohort study. J Acquir Immune Defic Syndr. 2016;71(1):e16–23.CrossRef Grimsrud A, Lesosky M, Kalombo C, Bekker LG, Myer L. Implementation and operational research: community-based adherence clubs for the management of stable antiretroviral therapy patients in Cape Town, South Africa: a cohort study. J Acquir Immune Defic Syndr. 2016;71(1):e16–23.CrossRef
15.
go back to reference Kagee A, Delport T. Barriers to adherence to antiretroviral treatment: the perspectives of patient advocates. J Health Psychol. 2010;15(7):1001–11.CrossRef Kagee A, Delport T. Barriers to adherence to antiretroviral treatment: the perspectives of patient advocates. J Health Psychol. 2010;15(7):1001–11.CrossRef
16.
go back to reference Kagee A, Nothling J, Coetzee B. The perspectives of users of antiretroviral therapy on structural barriers to adherence in South Africa. S Afr Fam Pract. 2012;54(6):506. Kagee A, Nothling J, Coetzee B. The perspectives of users of antiretroviral therapy on structural barriers to adherence in South Africa. S Afr Fam Pract. 2012;54(6):506.
17.
go back to reference Venables E, Edwards JK, Baert S, Etienne W, Khabala K, Bygrave H. “They just come, pick and go.” The acceptability of integrated medication adherence clubs for HIV and non communicable disease (NCD) patients in Kibera, Kenya. PLoS ONE. 2016;11(10):e0164634.CrossRef Venables E, Edwards JK, Baert S, Etienne W, Khabala K, Bygrave H. “They just come, pick and go.” The acceptability of integrated medication adherence clubs for HIV and non communicable disease (NCD) patients in Kibera, Kenya. PLoS ONE. 2016;11(10):e0164634.CrossRef
18.
go back to reference Khabala KB, Edwards JK, Baruani B, Sirengo M, Musembi P, Kosgei RJ, et al. Medication Adherence Clubs: a potential solution to managing large numbers of stable patients with multiple chronic diseases in informal settlements. Trop Med Int Health. 2015;20(10):1265–70.CrossRef Khabala KB, Edwards JK, Baruani B, Sirengo M, Musembi P, Kosgei RJ, et al. Medication Adherence Clubs: a potential solution to managing large numbers of stable patients with multiple chronic diseases in informal settlements. Trop Med Int Health. 2015;20(10):1265–70.CrossRef
19.
go back to reference Pellecchia U, Baert S, Nundwe S, Bwanali A, Zamadenga B, Metcalf CA, et al. “We are part of a family”. Benefits and limitations of community ART groups (CAGs) in Thyolo, Malawi: a qualitative study. J Int AIDS Soc. 2017;20(1):21374.CrossRef Pellecchia U, Baert S, Nundwe S, Bwanali A, Zamadenga B, Metcalf CA, et al. “We are part of a family”. Benefits and limitations of community ART groups (CAGs) in Thyolo, Malawi: a qualitative study. J Int AIDS Soc. 2017;20(1):21374.CrossRef
20.
go back to reference Roy M, Bolton C, Sikazwe I, Mukumbwa-Mwenechanya M, Efronson E, Somwe P, et al. Urban adherence clubs in Zambia: findings from model implementation. In: Oral abstract: 22nd international AIDS conference, 2018. Roy M, Bolton C, Sikazwe I, Mukumbwa-Mwenechanya M, Efronson E, Somwe P, et al. Urban adherence clubs in Zambia: findings from model implementation. In: Oral abstract: 22nd international AIDS conference, 2018.
21.
go back to reference Hanrahan CF, Schwartz SR, Mudavanhu M, West NS, Mutunga L, Keyser V, et al. The impact of community- versus clinic-based adherence clubs on loss from care and viral suppression for antiretroviral therapy patients: findings from a pragmatic randomized controlled trial in South Africa. PLoS Med. 2019;16(5):e1002808.CrossRef Hanrahan CF, Schwartz SR, Mudavanhu M, West NS, Mutunga L, Keyser V, et al. The impact of community- versus clinic-based adherence clubs on loss from care and viral suppression for antiretroviral therapy patients: findings from a pragmatic randomized controlled trial in South Africa. PLoS Med. 2019;16(5):e1002808.CrossRef
22.
go back to reference De Jager GA, Crowley T, Esterhuizen TM. Patient satisfaction and treatment adherence of stable human immunodeficiency virus-positive patients in antiretroviral adherence clubs and clinics. Afr J Prim Health Care Fam Med. 2018;10(1):e1–8.CrossRef De Jager GA, Crowley T, Esterhuizen TM. Patient satisfaction and treatment adherence of stable human immunodeficiency virus-positive patients in antiretroviral adherence clubs and clinics. Afr J Prim Health Care Fam Med. 2018;10(1):e1–8.CrossRef
23.
go back to reference McNutt LA, Wu C, Xue X, Hafner JP. Estimating the relative risk in cohort studies and clinical trials of common outcomes. Am J Epidemiol. 2003;157(10):940–3.CrossRef McNutt LA, Wu C, Xue X, Hafner JP. Estimating the relative risk in cohort studies and clinical trials of common outcomes. Am J Epidemiol. 2003;157(10):940–3.CrossRef
24.
go back to reference Creswell J, Plano Clark L. Designing and conducting mixed methods research. Thousand Oaks: SAGE Publications; 2007. Creswell J, Plano Clark L. Designing and conducting mixed methods research. Thousand Oaks: SAGE Publications; 2007.
25.
go back to reference Govindasamy D, Ford N, Kranzer K. Risk factors, barriers and facilitators for linkage to antiretroviral therapy care: a systematic review. AIDS. 2012;26(16):2059–67.CrossRef Govindasamy D, Ford N, Kranzer K. Risk factors, barriers and facilitators for linkage to antiretroviral therapy care: a systematic review. AIDS. 2012;26(16):2059–67.CrossRef
26.
go back to reference Geng EH, Nash D, Kambugu A, Zhang Y, Braitstein P, Christopoulos KA, et al. Retention in care among HIV-infected patients in resource-limited settings: emerging insights and new directions. Curr HIV/AIDS Rep. 2010;7(4):234–44.CrossRef Geng EH, Nash D, Kambugu A, Zhang Y, Braitstein P, Christopoulos KA, et al. Retention in care among HIV-infected patients in resource-limited settings: emerging insights and new directions. Curr HIV/AIDS Rep. 2010;7(4):234–44.CrossRef
27.
go back to reference Azia IN, Mukumbang FC, van Wyk B. Barriers to adherence to antiretroviral treatment in a regional hospital in Vredenburg, Western Cape, South Africa. S Afr J HIV Med. 2016;17(1):476.CrossRef Azia IN, Mukumbang FC, van Wyk B. Barriers to adherence to antiretroviral treatment in a regional hospital in Vredenburg, Western Cape, South Africa. S Afr J HIV Med. 2016;17(1):476.CrossRef
28.
go back to reference McGuire M, Munyenyembe T, Szumilin E, Heinzelmann A, Le Paih M, Bouithy N, et al. Vital status of pre-ART and ART patients defaulting from care in rural Malawi. Trop Med Int Health. 2010;15(Suppl 1):55–62.CrossRef McGuire M, Munyenyembe T, Szumilin E, Heinzelmann A, Le Paih M, Bouithy N, et al. Vital status of pre-ART and ART patients defaulting from care in rural Malawi. Trop Med Int Health. 2010;15(Suppl 1):55–62.CrossRef
29.
go back to reference Mhode M, Nyamhanga T. Experiences and impact of stigma and discrimination among people on antiretroviral therapy in Dar es Salaam: a qualitative perspective. AIDS Res Treat. 2016;2016:7925052.PubMedPubMedCentral Mhode M, Nyamhanga T. Experiences and impact of stigma and discrimination among people on antiretroviral therapy in Dar es Salaam: a qualitative perspective. AIDS Res Treat. 2016;2016:7925052.PubMedPubMedCentral
30.
go back to reference Brown L, Lee TH, De Allegri M, Rao K, Bridges JF. Applying stated-preference methods to improve health systems in sub-Saharan Africa: a systematic review. Expert Rev Pharmacoecon Outcomes Res. 2017;17(5):441–58.CrossRef Brown L, Lee TH, De Allegri M, Rao K, Bridges JF. Applying stated-preference methods to improve health systems in sub-Saharan Africa: a systematic review. Expert Rev Pharmacoecon Outcomes Res. 2017;17(5):441–58.CrossRef
Metadata
Title
Perceptions of Community and Clinic-Based Adherence Clubs for Patients Stable on Antiretroviral Treatment: A Mixed Methods Study
Authors
Mutsa Mudavanhu
Nora S. West
Sheree R. Schwartz
Lillian Mutunga
Valerie Keyser
Jean Bassett
Annelies Van Rie
Colleen F. Hanrahan
Publication date
01-04-2020
Publisher
Springer US
Published in
AIDS and Behavior / Issue 4/2020
Print ISSN: 1090-7165
Electronic ISSN: 1573-3254
DOI
https://doi.org/10.1007/s10461-019-02681-8

Other articles of this Issue 4/2020

AIDS and Behavior 4/2020 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.